Malignant Ovarian Endometrioid Tumor — Trials

Malignant Ovarian Endometrioid Tumor — Trials · CancerIndex

Clinical trials

Registered studies

75 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 13
Ph III recruiting: 4
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05950464	Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer	recruiting	Phase 1	65	National Cancer Institute (NCI)NIH	1	Sep 3, 2026	clinicaltrials
NCT06856499	Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer	recruiting	Phase 1	50	University of Colorado, DenverOTHER	1	Jul 24, 2026